Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimal Indications of Radioimmunotherapy in Nuclear Medicine: A Mini-Review.
Vahidfar N, Ahmadzadehfar H, Farzanefar S, Abbasi M, Salehi Y, Saboktakin F, Jahanbin M, Bakhshi Kashi M, Eppard E, Jürgen Biersack H. Vahidfar N, et al. Among authors: eppard e. Curr Radiopharm. 2024 Mar 19. doi: 10.2174/0118744710295825240308093429. Online ahead of print. Curr Radiopharm. 2024. PMID: 38504563
Recent Trends in Diagnostic Biomarkers of Tumor Microenvironment.
Siminzar P, Tohidkia MR, Eppard E, Vahidfar N, Tarighatnia A, Aghanejad A. Siminzar P, et al. Among authors: eppard e. Mol Imaging Biol. 2023 Jun;25(3):464-482. doi: 10.1007/s11307-022-01795-1. Epub 2022 Dec 14. Mol Imaging Biol. 2023. PMID: 36517729 Review.
An Impressive Approach in Nuclear Medicine: Theranostics.
Vahidfar N, Eppard E, Farzanehfar S, Yordanova A, Fallahpoor M, Ahmadzadehfar H. Vahidfar N, et al. Among authors: eppard e. PET Clin. 2021 Jul;16(3):327-340. doi: 10.1016/j.cpet.2021.03.011. PET Clin. 2021. PMID: 34053577 Review.
Theranostic Advances in Breast Cancer in Nuclear Medicine.
Vahidfar N, Aghanejad A, Ahmadzadehfar H, Farzanehfar S, Eppard E. Vahidfar N, et al. Among authors: eppard e. Int J Mol Sci. 2021 Apr 27;22(9):4597. doi: 10.3390/ijms22094597. Int J Mol Sci. 2021. PMID: 33925632 Free PMC article. Review.
Evaluation of Safety and Dosimetry of 177Lu-DOTA-ZOL for Therapy of Bone Metastases.
Fernández R, Eppard E, Lehnert W, Jiménez-Franco LD, Soza-Ried C, Ceballos M, Ribbeck J, Kluge A, Rösch F, Meckel M, Zhernosekov K, Kramer V, Amaral H. Fernández R, et al. Among authors: eppard e. J Nucl Med. 2021 Aug 1;62(8):1126-1132. doi: 10.2967/jnumed.120.255851. Epub 2021 Jan 8. J Nucl Med. 2021. PMID: 33419945 Free PMC article.
Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC.
Kramer V, Fernández R, Lehnert W, Jiménez-Franco LD, Soza-Ried C, Eppard E, Ceballos M, Meckel M, Benešová M, Umbricht CA, Kluge A, Schibli R, Zhernosekov K, Amaral H, Müller C. Kramer V, et al. Among authors: eppard e. Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):893-903. doi: 10.1007/s00259-020-05022-3. Epub 2020 Sep 19. Eur J Nucl Med Mol Imaging. 2021. PMID: 32949253 Free PMC article.
Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators.
Moon ES, Elvas F, Vliegen G, De Lombaerde S, Vangestel C, De Bruycker S, Bracke A, Eppard E, Greifenstein L, Klasen B, Kramer V, Staelens S, De Meester I, Van der Veken P, Rösch F. Moon ES, et al. Among authors: eppard e. EJNMMI Radiopharm Chem. 2020 Jul 29;5(1):19. doi: 10.1186/s41181-020-00102-z. EJNMMI Radiopharm Chem. 2020. PMID: 32728930 Free PMC article.
39 results